Author:
Oliviero Francesca,Sfriso Paolo,Punzi Leonardo,Dayer Jean-Michel
Subject
Pharmacology (medical),Pharmacology
Reference3 articles.
1. Therapeutic innovation in adult-onset Still's disease (and other rare inflammatory disorders): how to secure evidence-based medicine?;Guilpain;Ann. Rheum. Dis.,2018
2. Antiinflammatory therapy with canakinumab for atherosclerotic disease;Ridker;N. Engl. J. Med.,2017
3. Interleukin-1β inhibition with canakinumab associates with reduced rates of total hip and knee replacement (THR/TKR) and osteoarthritis (OA) symptoms: exploratory results from the canakinumab anti-inflammatory thrombosis outcomes study (CANTOS) [abstract]
SchiekerM.
MindeholmL.
PraestgaardJ.
ScottiC.
SolomonD.
ThurenT.
Arthritis Rheum702018
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献